MaterniT 21 PLUS is the only NIPT to offer GENOME-Flex, a new NIPT high risk pathway1
Once an NIPT test has been run and billed to insurance, future screening options for the MFM orobstetrician become limited should anomalies be suspected later in pregnancy.
A confirmatory diagnostic procedure may be recommended according to clinical practice and societyguidelines, but this option may not be desired by the patient. MaterniT 21 PLUS provides a new alternative,a pathway to rapidly re-sequence previously run MaterniT 21 PLUS samples using the deeper sequencingpower of MaterniT GENOME. Often no redraw is required*, results available in approximately 72 hours, and a different insurance billing path is followed (as shown below) saving considerable time by eliminating newappointments and waiting for test results as shown below.
MaterniT 21 PLUS will deliver many advantages to your practice, but most importantly it will give youback time
*In the rare case the initial MaterniT 21 PLUS specimen was used in its entirety during the initial test, a specimen redraw may be required.
|Specimen handling||Ordering GENOME-Flex||Rapid results|
- Illumina. https://www.illumina.com/clinical/illumina_clinical_laboratory/verifi-pr.... Accessed August 15, 2018.